Detalhe da pesquisa
1.
Quantitative proteomic analysis of HER2 protein expression in PDAC tumors.
Clin Proteomics
; 21(1): 24, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509475
2.
Integration of Multi-omic Data in a Molecular Tumor Board Reveals EGFR-Associated ALK-Inhibitor Resistance in a Patient With Inflammatory Myofibroblastic Cancer.
Oncologist
; 28(8): 730-736, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37255276
3.
Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study.
Oncologist
; 27(8): 623-e624, 2022 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429391
4.
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
N Engl J Med
; 378(8): 731-739, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29466156
5.
Studying the urine microbiome in superficial bladder cancer: samples obtained by midstream voiding versus cystoscopy.
BMC Urol
; 20(1): 5, 2020 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31992287
6.
Gut microbial composition difference between pediatric ALL survivors and siblings.
Pediatr Hematol Oncol
; 37(6): 475-488, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32427521
7.
Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients.
BMC Cancer
; 19(1): 357, 2019 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30991985
8.
Clinical and social factors associated with excess weight in Hispanic and non-Hispanic White children.
Pediatr Res
; 85(3): 256-261, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30643189
9.
EPG5 Variants with Modest Functional Impact Result in an Ameliorated and Primarily Neurological Phenotype in a 3.5-Year-Old Patient with Vici Syndrome.
Neuropediatrics
; 50(4): 257-261, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31226715
10.
A novel inborn error of the coenzyme Q10 biosynthesis pathway: cerebellar ataxia and static encephalomyopathy due to COQ5 C-methyltransferase deficiency.
Hum Mutat
; 39(1): 69-79, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29044765
11.
A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies.
Cancer
; 121(10): 1645-53, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25641763
12.
RAS Mutations Beyond KRAS Exon 2: A Review and Discussion of Clinical Trial Data.
Curr Treat Options Oncol
; 16(7): 33, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26050230
13.
A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061.
Cancer
; 120(8): 1194-202, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24474568
14.
Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicine.
Pharmacogenet Genomics
; 24(2): 81-93, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24401833
15.
Effectiveness of an Electronic Medical Record-Based Recognition Tool for the Identification of Incidental Pulmonary Nodules.
J Bronchology Interv Pulmonol
; 30(4): 373-378, 2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269849
16.
Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504.
Int J Radiat Oncol Biol Phys
; 115(4): 847-860, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36228746
17.
Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.
Elife
; 122023 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846664
18.
Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
medRxiv
; 2023 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37205429
19.
The rising challenge of non-AIDS-defining cancers in HIV-infected patients.
Clin Infect Dis
; 55(9): 1228-35, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22776851
20.
A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies.
Cancer
; 118(21): 5403-13, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22570147